Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis
-
Published:2024-04-17
Issue:5
Volume:56
Page:827-837
-
ISSN:1061-4036
-
Container-title:Nature Genetics
-
language:en
-
Short-container-title:Nat Genet
Author:
Ghouse JonasORCID, Sveinbjörnsson GardarORCID, Vujkovic MarijanaORCID, Seidelin Anne-Sofie, Gellert-Kristensen HeleneORCID, Ahlberg GustavORCID, Tragante ViniciusORCID, Rand Søren A.ORCID, Brancale JosephORCID, Vilarinho SilviaORCID, Lundegaard Pia RengtvedORCID, Sørensen Erik, Erikstrup ChristianORCID, Bruun Mie TopholmORCID, Jensen Bitten Aagaard, Brunak SørenORCID, Banasik KarinaORCID, Ullum Henrik, , Verweij Niek, Lotta LucaORCID, Baras ArisORCID, , Lotta Luca A.ORCID, Mirshahi ToorajORCID, Carey David J., , , Kaplan David E.ORCID, Lynch JulieORCID, Morgan Timothy, Schwantes-An Tae-Hwi, Dochtermann Daniel R., Pyarajan Saiju, Tsao Philip S., , Laisk TriinORCID, Mägi Reedik, Kozlitina JuliaORCID, Tybjærg-Hansen Anne, Jones David, Knowlton Kirk U., Nadauld Lincoln, Ferkingstad EgilORCID, Björnsson Einar S., Ulfarsson Magnus O., Sturluson Árni, Sulem PatrickORCID, Pedersen Ole B.ORCID, Ostrowski Sisse R.ORCID, Gudbjartsson Daniel F.ORCID, Stefansson KariORCID, Olesen Morten SallingORCID, Chang Kyong-Mi, Holm HilmaORCID, Bundgaard Henning, Stender StefanORCID
Abstract
AbstractWe report a multi-ancestry genome-wide association study on liver cirrhosis and its associated endophenotypes, alanine aminotransferase (ALT) and γ-glutamyl transferase. Using data from 12 cohorts, including 18,265 cases with cirrhosis, 1,782,047 controls, up to 1 million individuals with liver function tests and a validation cohort of 21,689 cases and 617,729 controls, we identify and validate 14 risk associations for cirrhosis. Many variants are located near genes involved in hepatic lipid metabolism. One of these, PNPLA3 p.Ile148Met, interacts with alcohol intake, obesity and diabetes on the risk of cirrhosis and hepatocellular carcinoma (HCC). We develop a polygenic risk score that associates with the progression from cirrhosis to HCC. By focusing on prioritized genes from common variant analyses, we find that rare coding variants in GPAM associate with lower ALT, supporting GPAM as a potential target for therapeutic inhibition. In conclusion, this study provides insights into the genetic underpinnings of cirrhosis.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Ginès, P. et al. Liver cirrhosis. Lancet Lond. Engl. 398, 1359–1376 (2021). 2. Huang, D. Q. et al. Global epidemiology of cirrhosis—aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388–398 (2023). 3. Loomba, R. et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149, 1784–1793 (2015). 4. Emdin, C. A. et al. Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene–environment interaction study. Gastroenterology 160, 1620–1633 (2021). 5. Gellert-Kristensen, H. et al. Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population. Hepatology 72, 845–856 (2020).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|